Sung Hwa Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sung Hwa Kang has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Eun Jeong Jang
Department of Surgery, Dong-A University College of Medicine, Dong-A University Medical Center, Busan, Korea
4 shared publications - Kwan Woo Kim
Department of Surgery, Dong-A University College of Medicine, Dong-A University Medical Center, Busan, Korea
4 shared publications - Yong-Kyu Chung
Inje University Haeundae Paik Hospital
4 shared publications - Cheon-Soo Park
Department of Surgery, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
2 shared publications - Min Chan Kim
Department of Surgery, College of Medicine, Dong-A University
2 shared publications - Song-Hee Han
Department of Pathology, Dong-A University College of Medicine, Busan, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (6) , 374-381
A minimally invasive approach to esophagojejunostomy leakage: a retrospective cohort study of the efficacy of endoscopic Histoacryl injection compared with conventional treatments
Kim MC, et al. Ann Surg Treat Res. 2026 Jun;110(6):374-381. https://doi.org/10.4174/astr.2026.110.6.374
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (6) , 374-381
Open AccessA minimally invasive approach to esophagojejunostomy leakage: a retrospective cohort study of the efficacy of endoscopic Histoacryl injection compared with conventional treatments
Kim MC, et al. Ann Surg Treat Res. 2026 Jun;110(6):374-381. https://doi.org/10.4174/astr.2026.110.6.374
- Open Access
- 15 December 2025
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 28 (4) , 184-192
Current status of treatment for esophagojejunostomy leakage after total gastrectomy in patients with gastric cancer: a multicenter retrospective study in Korea
Min-Chan Kim, Mi Ran Jung, Jeong Ju Noh, Sunghwa Kang, Jae Hun Chung, Ji-Ho Park, Tae-Han Kim, Jae Kyun Park, Yoonhong Kim, Sang Hyuk Seo, Sung Eun Kim, Oh Kyung Kwon, Ji Yeon Park, Ki Bum Park, Sun-Hwi Hwang, SI-Hak Lee, Young-Joon Lee, Sang-Ho Jeong, Tae-Yong Jeon, Dae Hwan Kim, Chang In Choi, Ki Young Yoon, Kyung Won Seo, Ki Hyun Kim, Sang Hoon Oh, Kwang Hee Kim. Journal of Minimally Invasive Surgery 2025;28:184-92. https://doi.org/10.7602/jmis.2025.28.4.184
- 15 December 2025
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 28 (4) , 184-192
Open AccessCurrent status of treatment for esophagojejunostomy leakage after total gastrectomy in patients with gastric cancer: a multicenter retrospective study in Korea
Min-Chan Kim, Mi Ran Jung, Jeong Ju Noh, Sunghwa Kang, Jae Hun Chung, Ji-Ho Park, Tae-Han Kim, Jae Kyun Park, Yoonhong Kim, Sang Hyuk Seo, Sung Eun Kim, Oh Kyung Kwon, Ji Yeon Park, Ki Bum Park, Sun-Hwi Hwang, SI-Hak Lee, Young-Joon Lee, Sang-Ho Jeong, Tae-Yong Jeon, Dae Hwan Kim, Chang In Choi, Ki Young Yoon, Kyung Won Seo, Ki Hyun Kim, Sang Hoon Oh, Kwang Hee Kim. Journal of Minimally Invasive Surgery 2025;28:184-92. https://doi.org/10.7602/jmis.2025.28.4.184
- Open Access
- 15 June 2024
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 27 (2) , 114-117
The method of using robotic Harmonic ACE curved shears for parenchymal transection in robotic hepatectomy
Eun Jeong Jang, Sung Hwa Kang, Kwan Woo Kim. Journal of Minimally Invasive Surgery 2024;27:114-7. https://doi.org/10.7602/jmis.2024.27.2.114
- 15 June 2024
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 27 (2) , 114-117
Open AccessThe method of using robotic Harmonic ACE curved shears for parenchymal transection in robotic hepatectomy
Eun Jeong Jang, Sung Hwa Kang, Kwan Woo Kim. Journal of Minimally Invasive Surgery 2024;27:114-7. https://doi.org/10.7602/jmis.2024.27.2.114
- 29 April 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-8
Exploring the feasibility of robotic liver resection in a limited resource setting
The transition from open hepatectomy to minimally invasive techniques has reduced morbidity and mortality. However, laparoscopic liver resection (LLR) requires substantial expertise. Robotic liver resection (RLR) combines minimal invasiveness with open surgical precision. It may facilitate complex procedures without the learning required for LLR. We evaluated RLR outcomes in a limited resource setting and assessed its efficacy and practicality. This retrospective study analyzed 67 robotic hepatectomies conducted from 2020 to 2023. Demographic, perioperative factors, and surgical outcomes were analyzed. Major hepatectomies were required in 46/67 (68.7%) patients who underwent RLR. No open conversions, 30-day mortalities, or readmissions occurred. Complications occurred in 7.4% of patients; major complications occurred in 5.9%. Learning curve analysis showed a negative correlation between operation sequence and operative time. Effective use of robotic technology combined with the expertise of well-trained surgeons facilitates successful execution of RLR with feasible surgical outcomes, even at smaller centers.
- 29 April 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-8
Exploring the feasibility of robotic liver resection in a limited resource setting
The transition from open hepatectomy to minimally invasive techniques has reduced morbidity and mortality. However, laparoscopic liver resection (LLR) requires substantial expertise. Robotic liver resection (RLR) combines minimal invasiveness with open surgical precision. It may facilitate complex procedures without the learning required for LLR. We evaluated RLR outcomes in a limited resource setting and assessed its efficacy and practicality. This retrospective study analyzed 67 robotic hepatectomies conducted from 2020 to 2023. Demographic, perioperative factors, and surgical outcomes were analyzed. Major hepatectomies were required in 46/67 (68.7%) patients who underwent RLR. No open conversions, 30-day mortalities, or readmissions occurred. Complications occurred in 7.4% of patients; major complications occurred in 5.9%. Learning curve analysis showed a negative correlation between operation sequence and operative time. Effective use of robotic technology combined with the expertise of well-trained surgeons facilitates successful execution of RLR with feasible surgical outcomes, even at smaller centers.
- Open Access
- 20 December 2023
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e942372-e942372-6
Intrahepatic Cholangiocarcinoma in Wilson’s Disease: A Case Report
Objective: Rare disease Background: Wilson's disease is a rare autosomal recessive disorder characterized by excessive accumulation of copper in the liver, brain, and kidneys. Although it affects only approximately 1 in 30 000 individuals, it leads to progressive liver damage and neurological issue. Wilson's disease presents a wide spectrum of clinical manifestations related to hepatic disease, ranging from asymptomatic cases to acute liver failure. The occurrence of hepatobiliary malignancies, including intrahepatic cholangiocarcinoma, is relatively uncommon in Wilson's disease, even among patients with cirrhosis. Only 14 cases have been published so far, including the present report, and its etiology remains unclear. Case Report: We report the successful treatment of intrahepatic cholangiocarcinoma in a 39-year-old woman with Wilson's disease. Twenty-two years after being diagnosed with Wilson's disease, intrahepatic cholangiocarcinoma was diagnosed. She had an intrahepatic mass that was found to be a 4.3 -cm ill-defined hypodense lesion in liver segment 3/4, with features suggesting infiltrative intrahepatic cholangiocarcinoma rather than hepatocellular carcinoma. Laboratory results showed slightly elevated liver enzymes and tumor markers. There was no evidence of metastasis on chest computed tomography or positron emission tomography, and the tumor was resectable, so surgery was the first-choice treatment option. Left hepatectomy was performed successfully, and the final pathology confirmed adenocarcinoma with clear resection margins. The patient received adjuvant chemotherapy with capecitabine. To date, the patient has been doing well without evidence of recurrence or metastasis. Conclusions: Despite limited knowledge regarding hepatic malignancy in Wilson's disease, it is crucial to prioritize careful monitoring and develop suitable treatment strategies upon diagnosis to achieve favorable outcomes, considering the potential occurrence of intrahepatic cholangiocarcinoma in Wilson's disease.
- 20 December 2023
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e942372-e942372-6
Open AccessIntrahepatic Cholangiocarcinoma in Wilson’s Disease: A Case Report
Objective: Rare disease Background: Wilson's disease is a rare autosomal recessive disorder characterized by excessive accumulation of copper in the liver, brain, and kidneys. Although it affects only approximately 1 in 30 000 individuals, it leads to progressive liver damage and neurological issue. Wilson's disease presents a wide spectrum of clinical manifestations related to hepatic disease, ranging from asymptomatic cases to acute liver failure. The occurrence of hepatobiliary malignancies, including intrahepatic cholangiocarcinoma, is relatively uncommon in Wilson's disease, even among patients with cirrhosis. Only 14 cases have been published so far, including the present report, and its etiology remains unclear. Case Report: We report the successful treatment of intrahepatic cholangiocarcinoma in a 39-year-old woman with Wilson's disease. Twenty-two years after being diagnosed with Wilson's disease, intrahepatic cholangiocarcinoma was diagnosed. She had an intrahepatic mass that was found to be a 4.3 -cm ill-defined hypodense lesion in liver segment 3/4, with features suggesting infiltrative intrahepatic cholangiocarcinoma rather than hepatocellular carcinoma. Laboratory results showed slightly elevated liver enzymes and tumor markers. There was no evidence of metastasis on chest computed tomography or positron emission tomography, and the tumor was resectable, so surgery was the first-choice treatment option. Left hepatectomy was performed successfully, and the final pathology confirmed adenocarcinoma with clear resection margins. The patient received adjuvant chemotherapy with capecitabine. To date, the patient has been doing well without evidence of recurrence or metastasis. Conclusions: Despite limited knowledge regarding hepatic malignancy in Wilson's disease, it is crucial to prioritize careful monitoring and develop suitable treatment strategies upon diagnosis to achieve favorable outcomes, considering the potential occurrence of intrahepatic cholangiocarcinoma in Wilson's disease.
- Open Access
- 1 April 2023
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 10, 643-658
Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma
Purpose: The six-transmembrane epithelial antigen of prostate 4 (STEAP4) has been linked to tumor progression via its involvement in inflammatory responses, oxidative stress, and metabolism. However, STEAP4 has rarely been studied in hepatocellular carcinoma (HCC). We explored STEAP4 expression associated with tumor prognosis to understand its role in tumor biology in HCC. Patients and Methods: STEAP4 mRNA and protein expressions were primarily analyzed using bioinformatics tools based on The Cancer Genome Atlas database to understand the expression pattern, molecular mechanism, prognostic impact, and association with immune cell infiltration. We further investigated the association between STEAP4 protein expression and clinicopathological parameters and their predictive value in HCC patients using immunohistochemical staining of tissue microarrays. Results: The expression of STEAP4 mRNA and protein in HCC tissues was significantly lower than in normal liver tissues. Reduced expression of STEAP4 was linked to advanced HCC stages, poor recurrence-free survival (RFS), and overall survival. Furthermore, reduced STEAP4 expression was a significant predictor of worse RFS in univariate and multivariate analyses in the immunohistochemical cohort. GO, KEGG, and GSEA analyses revealed that STEAP4 is related to numerous biological processes and pathways, including drug metabolism, DNA replication, RNA metabolism, and immune response. In terms of the immune system, the decreased level of STEAP4 was correlated with the immunosuppressive microenvironment. Conclusion: Our data indicated that reduced STEAP4 expression was significantly associated with tumor aggressiveness and poor prognosis, possibly because of its link to various biological processes and induction of HCC immune evasion. Therefore, STEAP4 expression may serve as a potential prognostic biomarker for cancer progression and immunity, as well as a therapeutic target in HCC.
- 1 April 2023
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 10, 643-658
Open AccessSix-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma
Purpose: The six-transmembrane epithelial antigen of prostate 4 (STEAP4) has been linked to tumor progression via its involvement in inflammatory responses, oxidative stress, and metabolism. However, STEAP4 has rarely been studied in hepatocellular carcinoma (HCC). We explored STEAP4 expression associated with tumor prognosis to understand its role in tumor biology in HCC. Patients and Methods: STEAP4 mRNA and protein expressions were primarily analyzed using bioinformatics tools based on The Cancer Genome Atlas database to understand the expression pattern, molecular mechanism, prognostic impact, and association with immune cell infiltration. We further investigated the association between STEAP4 protein expression and clinicopathological parameters and their predictive value in HCC patients using immunohistochemical staining of tissue microarrays. Results: The expression of STEAP4 mRNA and protein in HCC tissues was significantly lower than in normal liver tissues. Reduced expression of STEAP4 was linked to advanced HCC stages, poor recurrence-free survival (RFS), and overall survival. Furthermore, reduced STEAP4 expression was a significant predictor of worse RFS in univariate and multivariate analyses in the immunohistochemical cohort. GO, KEGG, and GSEA analyses revealed that STEAP4 is related to numerous biological processes and pathways, including drug metabolism, DNA replication, RNA metabolism, and immune response. In terms of the immune system, the decreased level of STEAP4 was correlated with the immunosuppressive microenvironment. Conclusion: Our data indicated that reduced STEAP4 expression was significantly associated with tumor aggressiveness and poor prognosis, possibly because of its link to various biological processes and induction of HCC immune evasion. Therefore, STEAP4 expression may serve as a potential prognostic biomarker for cancer progression and immunity, as well as a therapeutic target in HCC.
- Open Access
- 31 May 2022
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 2 (1) , 34-42
Diagnostic predictability of hepatocellular carcinoma tumor markers in patients waiting for living donor liver transplantation
Cheon-Soo Park, Yong-Kyu Chung, Sung-Hwa Kang, Shin Hwang. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.22.0012
- 31 May 2022
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 2 (1) , 34-42
Open AccessDiagnostic predictability of hepatocellular carcinoma tumor markers in patients waiting for living donor liver transplantation
Cheon-Soo Park, Yong-Kyu Chung, Sung-Hwa Kang, Shin Hwang. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.22.0012
- Open Access
- 31 May 2022
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 2 (1) , 8-14
Association between institutional liver transplantation cases volume and mortality: A meta-analysis of Korea-nationwide cohort studies using Korean National Healthcare Insurance Service database
Yong-Kyu Chung, Cheon-Soo Park, Sung-Hwa Kang. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.22.0011
- 31 May 2022
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 2 (1) , 8-14
Open AccessAssociation between institutional liver transplantation cases volume and mortality: A meta-analysis of Korea-nationwide cohort studies using Korean National Healthcare Insurance Service database
Yong-Kyu Chung, Cheon-Soo Park, Sung-Hwa Kang. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.22.0011
- Open Access
- 31 May 2022
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 2 (1) , 15-20
Analysis of the number of liver and kidney transplantations during COVID-19 pandemic in Korea: A report of years 2020 and 2021
- 31 May 2022
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 2 (1) , 15-20
Open AccessAnalysis of the number of liver and kidney transplantations during COVID-19 pandemic in Korea: A report of years 2020 and 2021
- Open Access
- 30 November 2021
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 1 (2) , 135-139
Analysis of nationwide volume of liver transplantation in Korea during 2020 shows no definitive decrease during COVID-19 outbreak
Yong-Kyu Chung, Sung-Hwa Kang. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.21.0026
- 30 November 2021
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 1 (2) , 135-139
Open AccessAnalysis of nationwide volume of liver transplantation in Korea during 2020 shows no definitive decrease during COVID-19 outbreak
Yong-Kyu Chung, Sung-Hwa Kang. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.21.0026